rs200177031
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_020751.3(COG6):c.511C>T(p.Arg171Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000224 in 1,610,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_020751.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COG6 | NM_020751.3 | c.511C>T | p.Arg171Ter | stop_gained | 5/19 | ENST00000455146.8 | NP_065802.1 | |
COG6 | NM_001145079.2 | c.511C>T | p.Arg171Ter | stop_gained | 5/19 | NP_001138551.1 | ||
COG6 | XM_011535168.2 | c.511C>T | p.Arg171Ter | stop_gained | 5/20 | XP_011533470.1 | ||
COG6 | NR_026745.1 | n.676C>T | non_coding_transcript_exon_variant | 6/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COG6 | ENST00000455146.8 | c.511C>T | p.Arg171Ter | stop_gained | 5/19 | 1 | NM_020751.3 | ENSP00000397441 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151994Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 251176Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135768
GnomAD4 exome AF: 0.0000213 AC: 31AN: 1458738Hom.: 0 Cov.: 29 AF XY: 0.0000234 AC XY: 17AN XY: 725866
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151994Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74238
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | COG6: PVS1, PM2, PM3 - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 18, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 26260076, 29709711, 32411386, 33394555, 35048409, 31589614, 32905044, 35068072, 34331832, 32730773, 34943782) - |
COG6-congenital disorder of glycosylation Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Center for Molecular Medicine, Children’s Hospital of Fudan University | May 10, 2019 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 22, 2018 | - - |
COG6-congenital disorder of glycosylation;C3809160:Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 14, 2021 | This sequence change creates a premature translational stop signal (p.Arg171*) in the COG6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COG6 are known to be pathogenic (PMID: 26260076). This variant is present in population databases (rs200177031, ExAC 0.005%). This premature translational stop signal has been observed in individual(s) with clinical features of COG6-CDG (PMID: 26260076). ClinVar contains an entry for this variant (Variation ID: 493007). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at